Mangrove Partners’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding VHAQ.WS
ASM
BFM
RCM
LA
KC
PAMP
M
CH
PC
PSAMP
Mangrove Partners's VHAQ.WS Position: Q2 2021 in Review
Mangrove Partners sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q2 2021, closing a stake of 405,377 shares — an estimated $154K sold.
Mangrove Partners first reported a position in VHAQ.WS in Q1 2021 and held it in 1 quarter. The position peaked at $154K in Q1 2021. 28 funds tracked by Wall St. Rank hold VHAQ.WS as of Q2 2021.
- Mangrove Partners reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q2 2021 after selling out during the quarter.
- Mangrove Partners sold 405,377 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q2 2021, an estimated $154K.
- Mangrove Partners first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q1 2021 and held it in 1 quarter.
- Mangrove Partners's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $154K in Q1 2021.
- 28 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q2 2021.
Based on Mangrove Partners's 13F filing for Q2 2021, filed 16 Aug 2021.